contraception basim abu-rafea, md, frcsc, facog assistant professor & consultant obstetrics...

45
CONTRACEPTION CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced Minimally Invasive Gynecologic Surgery Department of Obstetrics & Gynecology King Khalid University Hospital King Saud University

Upload: arabella-arline-preston

Post on 31-Dec-2015

223 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

CONTRACEPTIONCONTRACEPTIONBasim Abu-Rafea, MD, FRCSC, FACOG

Assistant Professor & ConsultantObstetrics & Gynecology

Reproductive Endocrinology & InfertilityAdvanced Minimally Invasive Gynecologic Surgery

Department of Obstetrics & GynecologyKing Khalid University Hospital

King Saud University

Page 2: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

ObjectivesObjectives Describe the advantages, disadvantages, failure

rates, and complications associated with the following methods of contraception

– Sterilization– Oral steroid contraception– Injectable steroid contraception– Implantable steroid contraception– Barrier methods– Natural family planning

Page 3: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

AbstinenceAbstinence

Mechanism: excludes sperm from female reproductive tract

Effectiveness: 0% failure rate

Ideal for adolescents at high risk for pregnancy and STD’s including HIV

Complications: None

Page 4: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Breastfeeding:Breastfeeding:Lactation Amenorrhea Method (LAM)Lactation Amenorrhea Method (LAM) Mechanism: Suckling causes increased prolactin,

which inhibits estrogen production and ovulation

2% typical use failure rate in 1st six mos.

Candidates:– Amenorrheic women < 6 mos post-partum who exclusively

breastfeed (90% of nutrition is breast milk)– Women free of blood-borne infections– Women not on drugs that could effect baby

Kennedy KI. et al., Contraceptive Technology.2004

Page 5: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

LAM ComplicationsLAM Complications

Breastfeeding may increase the risk of mastitis

Return of fertility or ovulation may precede menses.

33-45% ovulate during 1st 3 months.

Encourage backup form of contraception

Page 6: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Barrier Methods:Barrier Methods:Male CondomsMale Condoms

Page 7: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Barrier Methods:Barrier Methods:Male CondomsMale Condoms

Sheaths of latex, polyurethane, or natural membranes that may or may not have spermicide.

Mechanism: Barrier that prevents sperm and infections from entering vagina.

Effectiveness: 15% typical use failure rate.

Candidates:– Couples not in mutually monogamous relationships– Couples in which one partner has an STD/HIV– Couples starting other types of birth control– Couples who can’t use hormonal methods

Warner DL, et al. Contraceptive Technology. 2004

Page 8: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Barrier Method:Barrier Method:Female CondomFemale Condom

Disposable single use polyurethane sheath placed in vagina.

Flexible movable inner ring at closed end used to insert into vagina.

Flexible outer ring to cover part of the introitus.

Mechanism: Prevents passage of sperm and infections into the vagina.

Failure rate is high at 21% with typical use.

Hatcher et al. Managing Contraception.2004

Page 9: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Barrier Method:Barrier Method:Female CondomFemale Condom

Candidates the same as for male condoms.

Female condom is reusable only if the partner does not have an STD.

Disadvantages:

– Awkward and difficult to place – Most users do not enjoy using female condom (88% of

women and 91% of men)– Many couples complain about noise of condom

Page 10: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Female Condom: “Reality”Female Condom: “Reality”

Page 11: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Barrier Method:Barrier Method:Cervical CapCervical Cap

Thimble- shaped latex rubber device which has an inner ring that provides suction to keep cap on the cervix.

Spermicide is placed inside the cap before being placed on the cervix to kill sperm.

4 sizes: 22, 25, 28, 31 mm.

Mechanism: barrier that prevents sperm migration into cervical canal

Page 12: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Barrier Method:Barrier Method:Cervical CapCervical Cap

Advantages:– May decrease risk of GC, Chl, and PID– Can be placed 6 hours prior to intercourse– Can remain in vagina up to 48 hours for multiple

acts of intercourse

Disadvantages:– No protection against HIV– Poor fit especially in parous women– Failure Rate: As high as 32% in parous women and

16% in nulliparous women– Patient must leave in place at least 8 hours after

intercourse before removing

Page 13: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

DiaphragmDiaphragm

Page 14: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Barrier Method:Barrier Method:DiaphragmDiaphragm

Latex rubber dome-shaped device that covers the cervix

Mechanism: prevents sperm from entering cervical canal

Three types:

Arcing Spring Coil Spring Wide Seal

Page 15: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Barrier Method:Barrier Method:DiaphragmDiaphragm

Typical use failure rate: 16% in one year

May reduce risk of GC, Chl, PID

Risks: No protection from HIV Difficult to place around cervix May fall out in women with pelvic relaxation May cause vaginal erosions & infections May cause reaction in latex allergic Toxic Shock Syndrome Urinary Tract Infections

Page 16: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

SPERMICIDESPERMICIDE

Most common is nonoxynol-9

Available in creams, films, foams, gels, suppositories, sponges, and tablets

Best when used with barrier methods

29% typical use failure rate when used alone

Provides no protection against STD’s and HIV

Page 17: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Emergency Contraception (EC)Emergency Contraception (EC)

Any method used after unprotected or inadequately protected sexual intercourse

Three types of EC available in the United States:

High dose progestin only ( Plan B) Yuzpe method- 13 different combined oral contraceptives (Preven) Copper IUD ( Paragard)

Dickey. Managing Contraceptive Pill Patients, 2002

Page 18: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Emergency Contraception (EC)Emergency Contraception (EC)

Mechanism: Prevents fertilization and implantation.

Counsel patients that this method does not abort a pregnancy that is already implanted

Common in women after an assault or rape

Most women will have a cycle 21 days after completing emergency contraception

If patient does not have a cycle in 21 days, it is important to check a pregnancy test

Page 19: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Emergency Contraception (EC)Emergency Contraception (EC)

High dose progestin-only (Plan B):

1.5mg Norgestrel at one time or in divided doses.

Divided Dose: 1st dose within 72-120 hours of intercourse. 2nd dose 12 hours later.

One dose: Both tablets within 72-120 hours of intercourse

Glaser A. Emergency post-coital contraception, New England Journal of Medicine, 1997.

Page 20: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Emergency Contraception (EC)Emergency Contraception (EC)

Yuzpe Method (Preven)

– 100mcg of ethinyl estradiol and 0.50 mg of levonorgestrel in each dose.

– 1st dose within 72 hours of intercourse and 2nd dose 12 hours later

Page 21: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Emergency Contraception (EC)Emergency Contraception (EC)

Copper IUD

– Place within 5 days of unprotected coitus.

– This is usually given to women who plan to use the IUD for long term birth control.

– Interferes with implantation after fertilization.

Page 22: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Intrauterine DevicesIntrauterine Devices

Page 23: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Intrauterine Devices (IUDs)Intrauterine Devices (IUDs)

Copper IUD (Paragard T 380 A)

– Copper is a spermicide that inhibits sperm motility and acrosomal enzyme action

– Lasts 10-12 years

– May increase bleeding and dysmenorrhea

– Typical use failure rate is 0.8%

Mirena (Levonorgestrel)

– Increases thickness of cervical mucus to inhibit sperm migration

– Lasts up to 7 years

– Improves menorrhagia by 90% in most patients

– Causes amenorrhea in many users

– Typical use failure rate is 0.1%

Page 24: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

IUDIUD

Good for women in mutually monogamous relationships

Risks:

– Increased risk of PID within 1st 20 days– Uterine perforation– Fainting with insertion– Expulsion– Unexpected pregnancy following poor placement

Page 25: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Combined Oral ContraceptivesCombined Oral Contraceptives(Estrogen & Progestin)(Estrogen & Progestin)

Mechanism:

– Blocks ovulation

– Thickens cervical mucus

– Thins the endometrial lining

Page 26: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Combined Oral ContraceptivesCombined Oral Contraceptives(Estrogen & Progestin)(Estrogen & Progestin)

Ethinyl estradiol is the most commonly used estrogen in OCP’s

There are multiple forms of progestins

Monophasic: same amount of hormone in each active tablet

Multiphasic: varying amounts of hormone in each active pill

Most OCP’s have 21 active pills and 7 placebo pills

Page 27: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced
Page 28: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Combined Oral ContraceptivesCombined Oral Contraceptives(Estrogen & Progestin)(Estrogen & Progestin)

Alternate Formulations:

– Seasonale: 84 consecutive hormonal pills followed by 7 days of placebo

– Ovcon-35: chewable pills

– Yasmin: Drospirenone which is anti-androgenic and anti-mineralcorticoid

Page 29: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Combined Oral ContraceptivesCombined Oral Contraceptives(Estrogen & Progestin)(Estrogen & Progestin)

Non-contraceptive Uses of OCPs

– Dysfunctional uterine bleeding

– Dysmenorrhea

– Mittelschmerz

– Endometriosis prophylaxis

– Acne and hirsutism

– Hormone replacement

– Prevention of menstrual porphyria

– Functional ovarian cysts

Page 30: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Combined Oral ContraceptivesCombined Oral Contraceptives(Estrogen & Progestin)(Estrogen & Progestin)

Advantages:

– Less endometrial cancer (50% reduction)– Less ovarian cancer (40% reduction)– Less benign breast disease– Fewer ovarian cysts (50% to 80% reduction)– Fewer uterine fibroids (31% reduction)– Fewer ectopic pregnancies– Fewer menstrual problems

           --more regular           --less flow           --less dysmenorrhea           --less anemia

– Less salpingitis (pelvic inflammatory disease)– Less rheumatoid arthritis (60% reduction)– Increased bone density– Probably less endometriosis

Page 31: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Combined Oral ContraceptivesCombined Oral Contraceptives(Estrogen & Progestin)(Estrogen & Progestin)

Disadvantages

Spotting especially in 1st few months

May decrese Libido

Requires daily pill intake

No protection against STD’s and HIV

Possible weight gain

Post-contraception amenorrhea

Page 32: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Combined Oral ContraceptivesCombined Oral Contraceptives(Estrogen & Progestin)(Estrogen & Progestin)

Absolute Contraindications:

– Thromboembolic disorder (or history thereof)

– Cerebrovascular accident (or history thereof)

– Coronary artery disease (or history thereof)

– Impaired liver function (current)

– Hepatic adenoma (or history thereof)

– Breast cancer, endometrial cancer, other estrogen-dependant malignancies

– Pregnancy

– Undiagnosed vaginal bleeding

– Tobacco user over age 35

Page 33: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Combined Oral ContraceptivesCombined Oral Contraceptives(Estrogen & Progestin)(Estrogen & Progestin)

Relative Contraindications

– Migraine headaches, esp. worsening with pill use

– Hypertension

– Diabetes mellitus

– Elective surgery (needs 1 to 3 month discontinuation)

– Seizure disorder, anticonvulsant use

– Sickle cell disease (SS or sickle C disease (SC)

– Gall bladder disease.

Page 34: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Choosing The Right OCP’sChoosing The Right OCP’s

Endometriosis: Choose a pill with a strong progestin to create a pseudo-pregnancy state

Functional Ovarian Cysts: High dose monophasic pill may be more effective

Androgen excess: Choose a pill with high estrogen/progestin ratio to reduce free testosterone and inhibit 5 reductase activity

Breastfeeding: Progestin -only pill

Page 35: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Transdermal: Ortho EvraTransdermal: Ortho Evra

Delivers 20 mcg of ethinyl estradiol and 150 mcg of norelgestromin daily

Takes 3 days to achieve a steady state of hormone in the blood stream

Patch is replaced once per week for 3 consecutive weeks

Worn on abdomen, buttocks, upper outer arm, or upper torso

Do not place on the breast

Page 36: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Transdermal: Ortho EvraTransdermal: Ortho Evra

Advantages:

– Only has to be replaced once per week

– May be taken continuously

Disadvantages:

– May slip off- provide pt. with an emergency patch

– Patch may be less effective in women who are > 198 pounds

Page 37: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Vaginal Contraceptive Ring: NuvaRingVaginal Contraceptive Ring: NuvaRing

Combined hormonal contraception consisting of a 5.4 cm diameter flexible ring

15 mcg ethinyl estradiol and 120 mcg of desogestrel

Mechanism: suppresses ovulation

Typical use failure rate: 8%

Page 38: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Vaginal Contraceptive Ring: NuvaRingVaginal Contraceptive Ring: NuvaRing

Place in vagina and remove after 3 weeks

Allow withdrawal bleeding and replace new ring

Steady low release state

Advantage is patient only has to remember to insert and remove the ring 1x/ month

May be placed anywhere in the vagina

Page 39: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Depo ProveraDepo Provera

150 mg IM every 3 months

Contraceptive level maintained for 14 weeks

Failure Rate: 3% typical use failure rate

Mechanism:

– Thickens cervical mucus– Blocks the LH surge– Initiate treatment during the first week of menses

Page 40: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Depo ProveraDepo Provera Advantages

– Long acting

– Estrogen-free

– Safe in breast-feeding

– Can be used in sickle-cell disease and seizure disorder

– Pt. does not have to take daily

– Increases milk quality in nursing mothers

Disadvantages

– Irregular bleeding (70% in first year)

– Breast tenderness

– Weight gain

– Depression

– Slow return of menses after stopping use

– Decreases HDL cholesterol

Page 41: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Female SterilizationFemale Sterilization

Interrupts the patency of fallopian tubes- thereby preventing fertilization

Failure rate: Depends on method used -ranges from 0.8-3.7%

May be performed through a mini-laparotomy incision , laparoscopically, or transcervically

Page 42: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Female SterilizationFemale Sterilization

Page 43: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Male SterilizationMale Sterilization

Page 44: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced

Male SterilizationMale Sterilization Vasectomy: ligate or cauterize the vas deferens

Mechanism: interrupts vas deferens preventing passage of sperm into seminal fluid

May be done under local anesthesia

Cheaper than female sterilization

Failure rate: < 0.15%

Use contraception until completely azospermic for two consecutive sperm counts ( usually takes 12 weeks or 10-20 ejaculations)

Does not affect ability to have an orgasm

Page 45: CONTRACEPTION Basim Abu-Rafea, MD, FRCSC, FACOG Assistant Professor & Consultant Obstetrics & Gynecology Reproductive Endocrinology & Infertility Advanced